SCHEMBL8429103

SCHEMBL8429103

CCCCS(=O)(=O)N(N)[C@](C(=O)O)(C(=C=O)c1ccccc1)c1cc(NC=NN)cc(C(F)(F)F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.36
CYP1A2 P05177 1/20 0.36
UBE2M P61081 4/20 0.35
DCUN1D1 Q96GG9 4/20 0.35
P2RX1 P51575 2/20 0.34
MAPT P10636 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CNR2 P34972 1/20 0.32
PSEN1 P49768 2/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32
APH1A Q96BI3 1/20 0.32
PSENEN Q9NZ42 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
NR2E1 Q9Y466 1/20 0.31
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8431176 0.89 UBE2M (0.34) UBE2MDCUN1D1RXFP1CNR2ALDH1A1
SCHEMBL8429207 0.81 P2RX1 (0.36) TRPA1CYP1A2P2RX1MAPTL3MBTL1
SCHEMBL8430805 0.81 DHODH (0.33) CYP1A2UBE2MDCUN1D1RXFP1CNR2
SCHEMBL8428876 0.80 P2RX1 (0.35) TRPA1CYP1A2P2RX1ALDH1A1AKR1C3
SCHEMBL8429040 0.78 P2RX1 (0.34) TRPA1CYP1A2P2RX1ALDH1A1AKR1C3
SCHEMBL8429290 0.75 CA1 (0.33) CYP1A2MAPTRXFP1ALDH1A1HTT
SCHEMBL8430880 0.73 CA1 (0.37) RXFP1ALDH1A1
SCHEMBL8429100 0.71 BCHE (0.34) TRPA1CYP1A2UBE2MDCUN1D1L3MBTL1
SCHEMBL8431037 0.70 DHODH (0.37) MAPTALDH1A1
SCHEMBL8430809 0.69 CA1 (0.32) MAPTALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5952381-A SELECTIVELY INHIBITING OR ANTAGONIZING THE INTEGRINS; ANTITUMOR AGENTS, ANTIARTHRITIC AGENTS, VIRICIDES, MICROBIOCIDES; TREATING OSTEOPOROSIS, SKIN DISORDERS G. D. SEARLE & CO. (US) 1999-09-14 US disclosed